Ticker HubNasdaq

AIMD

Ainos, Inc. Common Stock

COMPUTER PERIPHERAL EQUIPMENT, NECLatest afterhours mover

Latest price

$1.21+14.38%

As of Nov 13, 2026, 8:00 PM EST · Market data by Massive

Market cap

$9.2M

Volume

4.7M

Previous close

$1.06

Day range

$0.8333 – $1.33

Listed

Aug 8, 1996

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $0.6899Latest interval $1.21

Newsroom

Latest AIMD coverage

Nov 12, 2026

Midday Movers: POAS, GP, PLCE Lead the Small-Cap Scan

POAS led a group of 10 active small-cap stocks flagged for editorial review.

POASGPPLCEAIMD

Recent catalyst headlines

Ainos Secures Largest Order in Company History: $9 Million ASE Agreement for 5,000 Additional AI Nose Systems

Nov 12, 2026

Ainos Surpasses 3 Billion Real-World Chemical Data Points, Advancing Chemical Intelligence for Smart Factories

Oct 30, 2026

Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment

Sep 30, 2026

Company overview

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Industry: COMPUTER PERIPHERAL EQUIPMENT, NEC
Employees: 41
Headquarters: HOUSTON, TX
CIK: 0001014763

Company website View advanced chart

SEC filings

ARS

DEF 14A

8-K

10-Q

424B5

8-K

Browse EDGAR

Profile at a glance

Aug 8, 1996

Listed

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.